article thumbnail

Should you cast your net where the big fish swim?

Berkonomics

[Email readers, continue here…] I have been on the board of a services company that specializes in the middle of the market, knowing that very large competitors throw lots of resources at the largest accounts – resources that our company just does not have. A personal story about dealing with too large a company.

.Net 156
article thumbnail

Cast your net where the big fish swim.

Berkonomics

I am on the board of a services company that specializes in the middle of the market, knowing that very large competitors throw lots of resources at the largest accounts – resources that our company just does not have.

.Net 235
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AmpliPhi Biosciences Nets $9.1M From IPO

socalTECH

San Diego-based AmpliPhy Biosciences , a developer of therapies for treating drug-resistant bacterial infections using bacteriophage technology, said it raised $9.1M The company trades as APHB on the NYSE Small Cap Market. for the company in its IPO.

.Net 124
article thumbnail

Demand Media Nets $77.2M From IPO

socalTECH

in net proceeds from the firm's IPO last week. The firm, which debuted on the NYSE as DMD, said it will use the new funding for investments in content, international expansion, working capital, product development, sales and marketing activities, general and administrative matters and capital expenditures.

.Net 145
article thumbnail

A heartbreaking story about time and money.

Berkonomics

Since this number is budgeted and pre-authorized, managers tend to focus upon other things such as sales, marketing and product development issues. There is an art to efficient management of a process, whether that is the process of bringing a product to market from R&D to production or developing a new product’s launch program.

article thumbnail

Cast your net where the big fish swim.

Berkonomics

I am on the board of a services company that specializes in the middle of the market, knowing that very large competitors throw lots of resources at the largest accounts – resources that our company just does not have.

.Net 166
article thumbnail

Design Therapeutics Sets IPO Offering Range

socalTECH

Carlsbad-based Design Therapeutics, a company developing treatments for serious degenerative disorders, has set an expected IPO offering range of between $18.00 The company has applied to list on the Nasdaq Global Market as DSGN. The IPO offering would net the company around $276M, and value it at over $1.1 and $20.00

Design 113